Skip to main content
. 2018 Sep 25;10:1758835918797589. doi: 10.1177/1758835918797589

Figure 1.

Figure 1.

Flow chart describing enrollment of patients in the study.

EGFR, epidermal growth factor receptor; NSCLC, non-small cell lung cancer; TKI, tyrosine kinase inhibitor.